Dylan Zylla
HealthPartners
Quality of lifeCancerInternal medicineOncologyHealth careRandomized controlled trialPhysical therapyProspective cohort studyHazard ratioPatient satisfactionLung cancerChemotherapyCannabisTumor progressionOpioidPain medicineIn patientMedical cannabisAnesthesiaIncidence (epidemiology)Family medicineClinical trialDiabetes mellitusMedicine
30Publications
9H-index
484Citations
Publications 24
Newest
#1Dylan Zylla (HealthPartners)H-Index: 9
#2Justin Eklund (HealthPartners)H-Index: 3
Last. Arkadiusz Z. Dudek (HealthPartners)H-Index: 38
view all 13 authors...
PURPOSE The prevalence of medical cannabis (MC) use in patients with cancer is growing, but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled trials (RCTs) using state-sponsored MC programs is novel and could provide data needed to guide patients and providers. METHODS A pilot RCT of patients with stage IV cancer requiring opioids was conducted. Thirty patients were randomized 1:1 to early cannabis (EC, n = 15) versus delayed start cannabis (DC, n = 15). The ...
Source
#1Grant Steele (HealthPartners)H-Index: 5
#2Arkadiusz Z. Dudek (HealthPartners)H-Index: 38
Last. Dylan Zylla (HealthPartners)H-Index: 9
view all 7 authors...
OBJECTIVES Pancreatic adenocarcinoma is frequently associated with pain requiring opioid therapy. Opioids, however, have been implicated in causing tumor progression, ultimately shortening survival. We examined the impact of pain, opioid use, and the mu-opioid receptor (MOP-R) expression in tumor tissue on progression-free survival and overall survival of patients with metastatic pancreatic cancer. METHODS We identified 103 patients with metastatic pancreatic adenocarcinoma receiving chemotherap...
1 CitationsSource
#1Dylan Zylla (HealthPartners)H-Index: 9
#2Grace Gilmore (HealthPartners)H-Index: 3
Last. Alice C. Shapiro (HealthPartners)H-Index: 5
view all 7 authors...
Background Use of electronic patient-reported outcomes (ePROs) in routine cancer care can help identify troublesome symptoms and facilitate discussions between patients and clinicians and has been shown to improve patient satisfaction, quality of life, and survival.
6 CitationsSource
#1Jennifer S. Temel (Harvard University)H-Index: 66
#2Jeff A. Sloan (Mayo Clinic)H-Index: 141
Last. Charles L. Loprinzi (Mayo Clinic)H-Index: 110
view all 17 authors...
Background: We conducted a multicenter, randomized trial of early integrated palliative and oncology care in patients with advanced cancer to confirm the benefits of early palliative care (PC) seen...
6 CitationsSource
#1Benjamin Y. Urick (UNC: University of North Carolina at Chapel Hill)H-Index: 5
#2Angela M. StoverH-Index: 19
Last. Ethan BaschH-Index: 81
view all 8 authors...
e19175Background: As value-based oncology care models become increasingly common, there is need for reliable and valid patient-reported outcome performance measures (PRO-PMs) to assess quality of s...
Source
#1Angela M. Stover (UNC: University of North Carolina at Chapel Hill)H-Index: 19
#2Benjamin Y. Urick (UNC: University of North Carolina at Chapel Hill)H-Index: 5
Last. Ethan Basch (UNC: University of North Carolina at Chapel Hill)H-Index: 81
view all 28 authors...
PURPOSE:Patient-reported outcome measures (PROMs) that assess how patients feel and function have potential for evaluating quality of care. Stakeholder recommendations for PRO-based performance mea...
1 CitationsSource
#1Dylan Zylla (HealthPartners)H-Index: 9
#2Justin Eklund (HealthPartners)H-Index: 3
Last. Arkadiusz Z. Dudek (HealthPartners)H-Index: 38
view all 11 authors...
109Background: Higher pain and greater long-term opioid requirements have been associated with shorter survival and decreased quality of life (QOL) in patients with AC. Routine use of MC is limited...
1 CitationsSource
#1Angela M. StoverH-Index: 19
Last. E. M. BaschH-Index: 4
view all 20 authors...
Source
#1Angela M. StoverH-Index: 19
#2Ben Urick (UNC: University of North Carolina at Chapel Hill)H-Index: 2
Last. Ethan BaschH-Index: 81
view all 20 authors...
173Background: Symptom management is a cornerstone of quality oncology practice. ASCO established a Working Group to develop patient-reported outcome performance measures (PRO-PMs) for assessing sy...
Source
#1Dylan Zylla (HealthPartners)H-Index: 9
#2Grace Gilmore (HealthPartners)H-Index: 3
Last. Anders L. CarlsonH-Index: 6
view all 5 authors...
Abstract Background Glucocorticoids are commonly used in chemotherapy regimens and may lead to hyperglycemia and increased infection rates. Methods We performed a retrospective analysis on 1781 patients who received intravenous chemotherapy with glucocorticoids between 2010 and 2015. Data was obtained using electronic medical record, billing modules, and tumor registry. We compared new infections and survival between patients with and without diabetes, after adjusting for demographic and cancer-...
3 CitationsSource